What drives patients with psoriasis to seek care? Dr Steven Feldman and Professor Andrew Finlay, inventor of the Dermatology Life Quality Index, explore what matters most to patients.

Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/965160). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.

Resources

How is the severity of psoriatic arthritis and psoriasis usually assessed? https://www.medscape.com/answers/2196539-155443/how-is-the-severity-of-psoriatic-arthritis-and-psoriasis-is-usually-assessed

Dermatology Life Quality Index (DLQI) https://www.bad.org.uk/shared/get-file.ashx?id=1653&itemtype=document

Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2230.1994.tb01167.x

Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data https://www.karger.com/Article/FullText/365390

A Changed Life: The Life Experiences of Patients With Psoriasis Receiving Biological Treatment https://onlinelibrary.wiley.com/doi/10.1111/bjd.18876

Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/